Bacopa Monnieri
Ayurvedic herb studied for memory consolidation in human RCTs. Effects accumulate over 8-12 weeks - not an acute stimulant. A 2014 systematic review of 9 RCTs confirmed consistent improvements in memory and cognitive performance.
Mechanism
Bacopa monnieri (brahmi) is a well-characterised nootropic Ayurvedic herb whose active compounds - bacosides A and B - enhance kinase activity in the hippocampus, facilitating synaptic plasticity and the consolidation of new memories. Unlike acute stimulants, Bacopa's mechanism requires weeks of daily exposure to accumulate in tissue; 8-12 weeks is the typical trial duration used in clinical research.
A 2014 systematic review by Kongkeaw et al. assessed 9 double-blind RCTs and found consistent, significant improvements in memory free recall, retention, and cognitive performance. Bacopa also has adaptogenic properties - animal and human data suggest modulation of the stress-cortisol response, complementing Rhodiola in this formula.
Key Benefits
- Traditionally used in Ayurvedic preparations for over 2,000 years
- Research has examined bacosides A and B in the Bacopa family
- Effects accumulate over 8-12 weeks of daily use
- Adaptogenic - modulates stress-cortisol response
- ≥55% bacosides: full-spectrum, highest-grade standardisation
The Research
Peer-reviewed human trials supporting this ingredient at this dose.
Bacopa Monnieri
300mg≥55% bacosides - full-spectrum
Take with food - bacosides are fat-soluble and absorption increases with fat. Effects are cumulative over 8-12 weeks of daily use. Not an acute stimulant.